Publications

Journal Article
Research Support, Non-U.S. Gov't
Epublish 8 citations
Electronic publication date
September 21, 2021

View on Pubmed.gov 33717178 | View on doi.org 10.3389/fimmu.2...

Respiratory FimA-Specific Secretory IgA Antibodies Upregulated by DC-Targeting Nasal Double DNA Adjuvant Are Essential for Elimination of .

Search for publications in this journal Front Immunol

Abstract

Our previous studies showed that a combination of a DNA plasmid encoding Flt3 ligand (pFL) and CpG oligodeoxynucleotides 1826 (CpG ODN) (FL/CpG) as a nasal adjuvant provoked antigen-specific immune responses. In this study, we investigated the efficacy of a nasal vaccine consisting of FimA as the structural subunit of () fimbriae and FL/CpG for the induction of FimA-specific antibody (Ab) responses and their protective roles against nasal and lung infection by , a keystone pathogen in the etiology of periodontal disease. C57BL/6 mice were nasally immunized with recombinant FimA (FimA) plus FL/CpG three times at weekly intervals. As a control, mice were given nasal FimA alone. Nasal washes (NWs) and bronchoalveolar lavage fluid (BALF) of mice given nasal FimA plus FL/CpG resulted in increased levels of FimA-specific secretory IgA (SIgA) and IgG Ab responses when compared with those in controls. Significantly increased numbers of CD8- or CD11b-expressing mature-type dendritic cells (DCs) were detected in the respiratory inductive and effector tissues of mice given FimA plus FL/CpG. Additionally, significantly upregulated Th1/Th2-type cytokine responses by FimA-stimulated CD4 T cells were noted in the respiratory effector tissues. When mice were challenged with live the nasal route, mice immunized nasally with FimA plus FL/CpG inhibited colonization in the nasal cavities and lungs. In contrast, controls failed to show protection. Of interest, when IgA-deficient mice given nasal FimA plus FL/CpG were challenged with nasal , the inhibition of bacterial colonization in the respiratory tracts was not seen. Taken together, these results show that nasal FL/CpG effectively enhanced DCs and provided balanced Th1- and Th2-type cytokine response-mediated FimA-specific IgA protective immunity in the respiratory tract against A nasal administration with FimA and FL/CpG could be a candidate for potent mucosal vaccines for the elimination of inhaled in periodontal patients.

References

J Immunol. 2004 Mar 15;172(6):3612-9

Vaccine. 2008 Sep 2;26(37):4849-59

J Immunol. 2008 Jun 15;180(12):8126-34

J Immunol. 1999 Mar 1;162(5):2530-7

Cited by 8 citations (total)

Journal Article Research Support, Non-U.S. Gov't

Human salivary protein-derived peptides specific-salivary SIgA antibodies enhanced by nasal double DNA adjuvant in mice play an essential role in preventing Porphyromonas gingivalis colonization: an in-vitro study.

Electronic publication date March 3, 2023

Search for publications in this journal BMC Oral Health

Kayo Koyanagi [...] Tatsuro Miyake et al.

BACKGROUND

We previously showed that fimbriae-bore from Poryphyromonas gingivalis (Pg), one of the putative periodontopathogenic bacteria specifically bound to a peptide...

Journal Article

HA2-FimA DNA Vaccine Treats Experimental Periodontitis.

Electronic publication date April 30, 2024

Search for publications in this journal Oral Health Prev Dent

Huijie Zhang [...] Guohui Bai et al.

PURPOSE

To study the therapeutic effect of hemagglutinin-2 and fimbrial (HA2-FimA) vaccine on experimental periodontitis in rats.

MATERIALS AND METHODS

The first batch...

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial and financial relationships that could be construed as a potential conflict of interest. The reviewer SM declared a shared affiliation with one of the authors, KF, to the handling editor at the time of review. The reviewer ZM declared a shared affiliation with one of the authors, KF, to the handling editor at the time of review.

MeSH

Specialties

Substances

Copyright

Copyright © 2021 Kataoka, Kawabata, Koyanagi, Hashimoto, Miyake and Fujihashi.